DTIL
Precision Biosciences Inc
Halal Rating :
Last Price
$4.96
Last updated:
Market Cap
-
7D Change
-13.59%
1 Year Change
1233.69%
Company Overview
Industries
Exchange
Next Earnings Date
Precision BioSciences Inc is a clinical-stage biotechnology company dedicated to utilizing its proprietary ARCUS® genome editing platform to develop allogeneic CAR T and in vivo gene editing therapies. The company focuses on developing treatments for cancer and genetic diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $576000.0 | $22.11m | - | $256000.0 | 0.00% | 1.16% |
| June 30, 2024 | $49.9m | $26.5m | - | $560000.0 | 0.00% | 2.11% |
| March 31, 2024 | $17.58m | $22.34m | - | $574000.0 | 0.00% | 2.57% |
Company Impact
Help us evaluate Precision Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.